Clinical Trial

Improving Menstrual and VAginal Health for All

Study acronym: IMVAHA
Recruiting
View on ClinicalTrials.gov →
Summary
A three-period crossover trial will study the effects of short-term use of 3 menstrual products (menstrual pad, tampon, menstrual cup) on the bacterial composition of the vaginal microbiome in three countries (Peru, Cameroon, and Switzerland). Each crossover period consists of two menstrual cycles, thus resulting in a 6-month trial. Participants will be randomly assigned to one of 6 exposure sequences (different order of products per sequence); in each sequence, participants will adopt each menstrual product for 2 menstrual cycles. Participants will provide vaginal microbiome samples via self-sample swabs at 3 points during each menstrual cycle. Given the crossover design of the study, there is not a dedicated control group.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-24
notable Primary completion pushed: 2026-08 -> 2026-12-31 2026-04-24
minor Completion pushed: 2026-12 -> 2026-12-31 2026-04-24
Trial Details
NCT Number NCT06646185
Lead Sponsor Swiss Tropical & Public Health Institute
Collaborators: Universidad Nacional de la Amazonia Peruana, Universidad Peruana Cayetano Heredia, Centre de Recherche sur les Maladies Emergentes et Re-Emergentes, Universiteit Antwerpen
Conditions Effects of Menstrual Products on the Vaginal Microbiome
Enrollment 100 participants
Start Date 2026-04-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-23